Startseite Medizin Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram

  • Mahacita Andanalusia , Umi Athiyah und Yunita Nita EMAIL logo
Veröffentlicht/Copyright: 18. Dezember 2019
Journal of Basic and Clinical Physiology and Pharmacology
Aus der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology Band 30 Heft 6

Abstract

Background

The prevalence of diabetes mellitus continues to increase every year, including in Indonesia. To prevent complications of diabetes mellitus, patients need to adhere to therapy. The aim of this study was to assess patient adherence to diabetes mellitus drug therapy at Tanjung Karang Primary Health Care Center, Mataram.

Methods

A total of 60 participants were recruited in April–May 2019. The inclusion criteria of respondents were patients who were diagnosed with diabetes mellitus, treated at Tanjung Karang Primary Health Care Center for more than 1 month, and aged at least 18 years. Assessment of adherence to therapy was carried out using a validated questionnaire, which was the Adherence to Refill Medication Scale (ARMS) questionnaire. The scale used was the Likert scale (1–4) with a score range of 12–48. The higher the total score, the lower the compliance.

Results

The average age of the respondents was 54.97 years. The average ARMS score was 19.52 ± 5.688 with the lowest score of 12 and the highest score of 33. Among all respondents, only 8.3% had good adherence (total score of 12). Based on the subscales, the average score for refilling medicine and intentional nonadherence in taking medicine was 7.18 ± 2.383, the unintentional nonadherence in taking medicine was 8.13 ± 2.764, and the persistence in refilling medicine was 4.12 ± 1.738.

Conclusions

Patient medication adherence to the treatment of diabetes mellitus needs to be improved. An approach through healthcare professionals can be achieved so that the therapeutic outcome will be achieved.

Keywords: adherence to refill medicine; diabetes mellitus; intended nonadherence; medication adherence; unintended nonadherence

Acknowledgments

We thank the stakeholders of Tanjung Karang Primary Health Care Center in Mataram and our colleagues in Universitas Airlangga for technical assistance.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by the authors’ institutional review board or equivalent committee.

References

[1] World Health Organization. Global report on diabetes 2016. Available at: https://apps.who.int/iris/bitstream/handle/10665/204871/9789241 565257_eng.pdf;jsessionid=FD11C00AF33B0700FB5B364A997246D9?sequence=1. Accessed 19 January 2019.Suche in Google Scholar

[2] International Diabetes Federation. IDF diabetes atlas, 8th ed. 2017. Available at: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/134-idf-diabetes-atlas-8th-edition.html.Suche in Google Scholar

[3] Kementerian Kesehatan RI. Hasil Utama Riskesdas 2018. Available at: http://www.depkes.go.id/resources/download/info-terkini/materi_rakorpop_2018/Hasil%20Riskesdas%202018.pdf.Suche in Google Scholar

[4] Dinas Kesehatan Provinsi NTB. Profil Kesehatan Provinsi Nusa Tenggara Barat tahun 2017. Available at: http://dinkes.ntbprov.go.id/profil-kesehatan/.Suche in Google Scholar

[5] American Diabetes Association. Glycemic targets: standard of medical care in diabetes 2018. Diabetes Care 2018;41:55–64.10.2337/dc18-S006Suche in Google Scholar

[6] Feldman BS, Cohen-stavi CJ, Leibowitz M, Hoshen MB, Singer SR, Bitterman H, et al. Defining the role of medication adherence in poor glycemic control among general adult population with diabetes. PLoS One 2014;9:1–9.10.1371/journal.pone.0108145Suche in Google Scholar

[7] World Health Organization. Adherence to long-term therapies: evidence for action. Available at: https://www.who.int/chp/knowledge/publications/adherence_report/en/.Suche in Google Scholar

[8] Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the patient-centered approach to medication management services, 3rd ed. New York: McGraw Hill Education, 2012.Suche in Google Scholar

[9] Rosyida L, Priyandani Y, Sulistyarini A, dan Nita Y. Kepatuhan Pasien Pada Penggunaan Obat Antidiabetes Dengan Metode Pill-Count Dan MMAS-8 Di Puskesmas Kedurus Surabaya. Jurnal Farmasi Komunitas 2015;2:36–41.Suche in Google Scholar

[10] Alfian SD, Sukandar H, Lestari K, Abdulah R. Medication adherence contributes to an improved quality of life in type 2 diabetes mellitus patients: a cross-sectional study. Diabetes Ther 2016;7:755–64.10.1007/s13300-016-0203-xSuche in Google Scholar

[11] Adikusuma W, Qiyaam N. Hubungan Tingkat Kepatuhan Minum Obat Antidiabetik Oral terhadap Kadar Hemoglobin Terglikasi (HbA1c) pada Pasien Diabetes Melitus Tipe 2. J. Ilm. Ibnu Sina 2017;2:279–86.Suche in Google Scholar

[12] Lemeshow S, Hosmer Jr DW, Klar J, Lwanga SK. Adequacy of sample size in health studies. Singapore: John Wiley & Sons Inc., 1990.Suche in Google Scholar

[13] Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value Health 2009;12:118–23.10.1111/j.1524-4733.2008.00400.xSuche in Google Scholar

[14] Nita Y, Saputra FM, Damayanti S, Pratiwi PI, Zukhairah R, Sulistyarini A, et al. Medication adherence in the elderly with chronic disease using the Adherence to Refill and Medication Scale (ARMS). Unity in Diversity and the Standardization of Clinical Pharmacy Services, 2018:175–8.10.1201/9781315112756-30Suche in Google Scholar

[15] Kim CJ, Park E, Schlenk EA, Kim M, Kim DJ. Psychometric evaluation of a Korean version of the Adherence to Refills and Medication Scale (ARMS) in adults with type 2 diabetes. Diabetes Educ 2016;42:188–98.10.1177/0145721716632062Suche in Google Scholar

[16] Mihardja L, Soetrisno U, Soegondo S. Prevalence and clinical profile of diabetes mellitus in productive aged urban Indonesians. J Diabetes Invest 2014;5:507–12.10.1111/jdi.12177Suche in Google Scholar

[17] Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a 2013 systemic analysis for the global burden of disease study. Lancet 2014;384:766–81.10.1016/S0140-6736(14)60460-8Suche in Google Scholar

[18] Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology, and complication of type 2 diabetes mellitus. Endocr Rev 2016;27:278–316.10.1210/er.2015-1137Suche in Google Scholar PubMed PubMed Central

[19] Triplitt CL, Reasner CA, Isley WI. Diabetic. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy. A pathophysiologic approach, 7th ed. New York: McGraw-Hill; 2008.Suche in Google Scholar

[20] Murad MA, Abdulmageed SS, Iftikhar R, Sagga BK. Assessment of the common risk factors associated with type 2 diabetes mellitus in Jeddah. Int J Endocrinol 2014;616145:1–9.10.1155/2014/616145Suche in Google Scholar PubMed PubMed Central

[21] Min H, Chang J, Balkrishnan R. Sociodemographic risk factors of diabetes and hypertension prevalence in Republic of Korea. Int J Hypertens 2010;410794:1–6.10.4061/2010/410794Suche in Google Scholar PubMed PubMed Central

[22] Eaton WW, Muntaner C. Socioeconomic stratification and mental disorder. In: Horwitz AV, Scheid TL, editors. Sociology of mental health and illness. New York: Cambridge University Press, 1999.Suche in Google Scholar

[23] Smith JP. The impact of socioeconomic status on health over the life-course. J Hum Resour 2007;42:739–64.10.3368/jhr.XLII.4.739Suche in Google Scholar

[24] American Diabetes Association. Pharmacologic approaches to glycemic treatment: standard medical care in diabetes. Diabetes Care 2018;41:73–85.10.2337/dc18-S008Suche in Google Scholar PubMed

[25] Menteri Kesehatan RI. Keputusan Menteri Kesehatan RI Nomor HK.01.07/MENKES/659/2017 tentang Formularium Nasional, 2017.Suche in Google Scholar

[26] Ohishi M. Hypertension with diabetes mellitus: physiology and pathology. Hypertens Res 2018;41:389–93.10.1038/s41440-018-0034-4Suche in Google Scholar PubMed

[27] Vergès B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia 2015;58:886–99.10.1007/s00125-015-3525-8Suche in Google Scholar PubMed PubMed Central

[28] Kushiyama A, Tanaka K, Hara S, Kawazu S. Linking uric acid metabolism to diabetic complications. World J Diabetes 2014;5:787–95.10.4239/wjd.v5.i6.787Suche in Google Scholar PubMed PubMed Central

[29] Roy NT, Sajith M, Bansode MP. Assessment of factors associated with low adherence to pharmacotherapy in elderly patients. J Young Pharm 2017;9:272–6.10.5530/jyp.2017.9.53Suche in Google Scholar

[30] Gordon EJ, Gallant M, Sehgal AR, Conti D, Siminoff LA. Medication-taking among adult renal transplant recipients: barriers and strategies. Transpl Int 2009;22:534–45.10.1111/j.1432-2277.2008.00827.xSuche in Google Scholar PubMed PubMed Central

[31] Hincapie AL, Taylor AM, Boesen KP, Warholak T. Understanding reasons for nonadherence to medications in a Medicare Part D beneficiary sample. J Manag Care Spec Pharm 2015;21:391–9.10.18553/jmcp.2015.21.5.391Suche in Google Scholar PubMed

[32] Atinga RA, Yarney L, Gavu NM. Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: a qualitative investigation. PLoS One 2018;13:1–15.10.1371/journal.pone.0193995Suche in Google Scholar PubMed PubMed Central

[33] Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol 2013;4:1–16.10.3389/fphar.2013.00091Suche in Google Scholar PubMed PubMed Central

[34] Okuboyejo S. Non-adherence to medication in outpatient setting in Nigeria: the effect of employment status. Glob J Health Sci 2014;6:37–44.10.5539/gjhs.v6n3p37Suche in Google Scholar PubMed PubMed Central

[35] Horne R, Weinman J, Barber N, Elliott R, Morgan M. Concordance, adherence, and compliance in medicine taking. National Co-ordinating Center for NHS Service Delivery and Organization R & D, 2005;1–331.10.1378/chest.130.1_suppl.65SSuche in Google Scholar PubMed

Received: 2019-10-02
Accepted: 2019-11-12
Published Online: 2019-12-18

© 2019 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Reviews
  2. Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
  3. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
  4. Original Articles
  5. Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
  6. Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
  7. The contemporary role and potential of pharmacist contribution for community health using social media
  8. Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
  9. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
  10. Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
  11. Overview of therapeutic changes in antiepileptic drugs in adult patients
  12. Exploration of barriers affecting job satisfaction among community pharmacists
  13. Patients’ characteristics and their adherence to insulin therapy
  14. Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
  15. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
  16. Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
  17. Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
  18. Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
  19. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
  20. Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
  21. The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
  22. Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
  23. Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
  24. ADMET properties of novel 5-O-benzoylpinostrobin derivatives
  25. Development of nonalcoholic fatty liver disease model by high-fat diet in rats
  26. Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
  27. The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
  28. The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
  29. Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
  30. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
  31. Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
  32. Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
  33. Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
  34. The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
  35. Ternary solid dispersion to improve solubility and dissolution of meloxicam
  36. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
  37. o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
  38. The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
  39. Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
  40. Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
  41. Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
  42. Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
  43. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
  44. In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
  45. Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
  46. Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
  47. Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
  48. Case Report
  49. A case report of generalized tetanus in a 42-year-old man with dental infection
https://doi.org/10.1515/jbcpp-2019-0287
Schlagwörter für diesen Artikel
adherence to refill medicine; diabetes mellitus; intended nonadherence; medication adherence; unintended nonadherence

Artikel in diesem Heft

  1. Reviews
  2. Pharmacist contributions in the treatment of diabetes mellitus in Southeast Asia: a narrative review
  3. The implementation of a chronic disease management program (Prolanis) in Indonesia: a literature review
  4. Original Articles
  5. Quercetin attenuates acute predator stress exposure-evoked innate fear and behavioral perturbation
  6. Evaluating current practices and policies in the use of injectable medicines for treating myalgia in a primary care center in Pamekasan, Indonesia
  7. The contemporary role and potential of pharmacist contribution for community health using social media
  8. Evaluation of rational drug use based on World Health Organization prescribing indicators in a primary care center in Pamekasan East Java, Indonesia
  9. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting
  10. Factors affecting community pharmacist’s service for women with chronic diseases during pregnancy and breastfeeding: application of the Health Belief Model
  11. Overview of therapeutic changes in antiepileptic drugs in adult patients
  12. Exploration of barriers affecting job satisfaction among community pharmacists
  13. Patients’ characteristics and their adherence to insulin therapy
  14. Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients
  15. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia
  16. Translation, cultural adaptation, and validation of the quality of well being self-administered questionnaire in general population in Indonesia
  17. Knowledge, attitude, and practice of pharmacists towards management of hypertension in primary care centers
  18. Medication adherence in diabetes mellitus patients at Tanjung Karang Primary Health Care Center, Mataram
  19. Decreasing angiogenesis vasa vasorum through Lp-PLA2 and H2O2 inhibition by PSP from Ganoderma lucidum in atherosclerosis: in vivo diabetes mellitus type 2
  20. Antiaggregation effect of clopidogrel in coronary heart disease patients using omeprazole
  21. The effect of curcuma (Curcuma xanthorrizha roxb.) extract as an adjuvant of captopril therapy on cardiac histopathology of male mice (Mus musculus) with hypertension
  22. Coenzyme Q10 nanostructured lipid carriers as an inducer of the skin fibroblast cell and its irritability test in a mice model
  23. Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy
  24. ADMET properties of novel 5-O-benzoylpinostrobin derivatives
  25. Development of nonalcoholic fatty liver disease model by high-fat diet in rats
  26. Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor
  27. The relationship between the level of education and accuracy of insulin injection techniques in DM patients with measurement of HbA1c values
  28. The effect of premixed insulin to blood glucose concentration in patients with type 2 diabetes mellitus
  29. Intravenous insulin therapy in diabetes mellitus with hyperglycemic crisis and intercurrent illness
  30. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya
  31. Evaluation to the chemotherapy use in patients with diffuse large B-cell lymphoma
  32. Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatients
  33. Antineuroinflammation activity of n-butanol fraction of Marsilea crenata Presl. in microglia HMC3 cell line
  34. The enhancement of Arg1 and activated ERβ expression in microglia HMC3 by induction of 96% ethanol extract of Marsilea crenata Presl. leaves
  35. Ternary solid dispersion to improve solubility and dissolution of meloxicam
  36. Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide
  37. o-Hydroxycinnamic derivatives as prospective anti-platelet candidates: in silico pharmacokinetic screening and evaluation of their binding sites on COX-1 and P2Y12 receptors
  38. The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis
  39. Attenuation of IL-1ß on the use of glucosamine as an adjuvant in meloxicam treatment in rat models with osteoarthritis
  40. Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit
  41. Comparison of antibiotic prescriptions in adults and children with upper respiratory tract infections in Bangka Tengah primary health care centers
  42. Profile of sociodemographics, sources of infection, antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre, Indonesia
  43. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor
  44. In vitro equivalence of generic and branded amoxicillin tablet by microbiological assay method
  45. Knowledge and attitude: two fundamental factors that determine patient compliance in antibiotic therapy
  46. Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA)
  47. Effect of curcumin analogue synthetic product from cullilawan oil for the liver damage treatment in male mice (Mus musculus L.)
  48. Case Report
  49. A case report of generalized tetanus in a 42-year-old man with dental infection
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 14.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2019-0287/html?lang=de
Button zum nach oben scrollen